Home
About
Overview
Sharing Data
ORCID
Help
History (26)
?9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8.
Resins, Synthetic
Wounds, Penetrating
Psychology, Social
HuR as a molecular target for cancer therapeutics and immune-related disorders.
See All 26 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HuR as a molecular target for cancer therapeutics and immune-related disorders.
HuR as a molecular target for cancer therapeutics and immune-related disorders. Adv Drug Deliv Rev. 2022 09; 188:114442.
View in:
PubMed
subject areas
ELAV-Like Protein 1
Humans
Neoplasms
Neovascularization, Pathologic
RNA, Messenger
RNA-Binding Proteins
authors with profiles
Shikhar Mehrotra
Viswanathan Palanisamy
Mrinmoyee Majumder
Paramita Chakraborty